Epigenetics in Cancer 2019
The study of epigenetics and chromosome dynamics has reshaped our understanding of tumor biology for over a decade. This second “Epigenetics in Cancer” symposium will bring together leaders in basic and translational research to promote a better understanding of epigenetic pathways as drug targets in cancer therapy.
The symposium is organized by The Wistar Institute’s Gene Expression and Regulation Program.
The Wistar Institute
3601 Spruce Street
Philadelphia, PA, 19104
Thank you to our sponsors:
|
|
|
|
Also supported by Cayman Chemical Company.
Keynote Speakers
Shelley L. Berger, Ph.D.
Director, Epigenetic Institute
Perelman School of Medicine University of Pennsylvania
Kristian Helin, Ph.D.
Chair, Cell Biology Program
Director, Center for Epigenetics
Memorial Sloan Kettering Cancer Center
Speakers
Ben E. Black, Ph.D.
University of Pennsylvania
Alessandro Gardini, Ph.D.
The Wistar Institute
Cigall Kadoch, Ph.D.
Dana-Farber Cancer Institute and Harvard Medical School
Kazuko Nishikura, Ph.D.
The Wistar Institute
Agnel Sfeir, Ph.D.
New York University
Emmanuel Skordalakes, Ph.D.
The Wistar Institute
Johnathan Whetstine, Ph.D.
Fox Chase Cancer Center/ Harvard Medical School